These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22945290)

  • 1. Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy.
    Jayalakshmi K; Sonkar K; Behari A; Kapoor VK; Sinha N
    NMR Biomed; 2011 May; 24(4):335-42. PubMed ID: 22945290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
    Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
    J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
    Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
    Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.
    Puhalla H; Herberger B; Soleiman A; Filipits M; Laengle F; Gruenberger T; Wrba F
    Anticancer Res; 2005; 25(6B):4249-54. PubMed ID: 16309224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthogranulomatous cholecystitis: a premalignant condition?
    Ghosh M; Sakhuja P; Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stones from cancerous and benign gallbladders are different: A proton nuclear magnetic resonance spectroscopy study.
    Srivastava M; Sharma A; Kapoor VK; Nagana Gowda GA
    Hepatol Res; 2008 Oct; 38(10):997-1005. PubMed ID: 18507688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
    Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
    J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
    Rao RV; Kumar A; Sikora SS; Saxena R; Kapoor VK
    Trop Gastroenterol; 2005; 26(1):31-3. PubMed ID: 15974235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlated expression of inducible nitric oxide synthase and P53, Bax in benign and malignant diseased gallbladder.
    Zhang M; Pan JW; Ren TR; Zhu YF; Han YJ; Kühnel W
    Ann Anat; 2003 Dec; 185(6):549-54. PubMed ID: 14704000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
    Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes involved in phosphatidylcholine biosynthesis correlate with nuclear factor-κB in biliary tract cancer patients: Evidence from
    Shekher A; Tiwari AK; Awasthee N; Verma SS; Dixit VK; Sinha N; Gupta SC; Puneet
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158970. PubMed ID: 34023500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid state (13)C NMR analysis of human gallstones from cancer and benign gall bladder diseases.
    Jayalakshmi K; Sonkar K; Behari A; Kapoor VK; Sinha N
    Solid State Nucl Magn Reson; 2009 Sep; 36(1):60-5. PubMed ID: 19577439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Ultrasound in Differentiating Xanthogranulomatous Cholecystitis from Gallbladder Carcinoma.
    Zhang F; Chen W; Zhang L; Hou C; Zhang M
    Ultrasound Med Biol; 2019 Nov; 45(11):2925-2931. PubMed ID: 31447238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative analysis of morphological manifestations of cholesterosis and concomitant pathology of the gall bladder].
    Khomeriki SG; Orlova IuN; Il'chenko AA; Chikunova BZ; Chekmazov IA; Morozov IA
    Arkh Patol; 2004; 66(5):12-5. PubMed ID: 15575378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
    Kalekou H; Miliaras D
    Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthogranulomatous cholecystitis: report of seven cases.
    Reyes CV; Jablokow VR; Reid R
    Am Surg; 1981 Jul; 47(7):322-5. PubMed ID: 7258841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histogenesis of gallbladder cancer with special reference to metaplastic changes and distribution of various mucins and CEA].
    Inada A; Konishi F; Yamamichi N; Ito H
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):894-906. PubMed ID: 2796960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of xanthogranulomatous cholecystitis: experience in 33 cases.
    Yang T; Zhang BH; Zhang J; Zhang YJ; Jiang XQ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):504-8. PubMed ID: 17897914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthogranulomatous cholecystitis: a chronic inflammatory pseudotumor of the gallbladder.
    Howard TJ; Bennion RS; Thompson JE
    Am Surg; 1991 Dec; 57(12):821-4. PubMed ID: 1746802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
    Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
    Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.